| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |